Trials / Unknown
UnknownNCT03818555
Sebacia Postmarket Study of Real-World Use
A Prospective, Multicenter, Postmarket Study of Sebacia Microparticles Treatment in Patients Using Topical Acne Products for Mild to Moderate Inflammatory Acne Vulgaris
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- Sponsor
- Sebacia, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Postmarket study of Sebacia Microparticles treatment during adoption into clinical use for patients with mild to moderate inflammatory acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sebacia Microparticles Treatment | Sebacia Microparticles procedure involving microparticles and 1064 nm laser. Three treatment procedures over a two-week period. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2019-01-28
- Last updated
- 2020-10-27
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03818555. Inclusion in this directory is not an endorsement.